Skip to main content

Advertisement

Log in

IgG4-related spinal pachymeningitis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study is to study the clinical, laboratory, imaging pathology, and prognosis features of IgG4-related spinal pachymeningitis. We worked with a 55-year-old man suffering from IgG4-related spinal pachymeningitis who had the most widespread lesion in his dura mater. We also review previous related studies and discuss the clinical characteristics of this rare disease. In total, eight IgG4-related spinal pachymeningitis patients have been reported in the literature since 2009. They were mostly male patients, 51.7 ± 11.9 years old on average. Cervical and thoracic vertebrae were the most common sites for lesions. The most prominent symptom was varying numbness and weakness of the limbs and/or body associated with spinal cord compression. There was one patient (1/5) with elevated serum IgG4 levels and three patients (3/3) with increased cerebrospinal fluid (CSF) IgG4 index. Positive histopathologic findings are the strongest basis for a diagnosis. All the patients with IgG4-related spinal pachymeningitis responded well to glucocorticoid therapy. IgG4-related spinal pachymeningitis is an orphan disease that mainly occurs in cervical and thoracic vertebrae. Older males are the most susceptible group. Serum IgG4 levels were consistently normal in these cases, so analysis of CSF for IgG4 production (IgG4 index) could become a useful tool. Pathological findings remain the gold standard for diagnosis. Most patients responded favorably to glucocorticoid treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366(6):539–51

    Article  CAS  PubMed  Google Scholar 

  2. Masaki Y, Dong L, Kurose N et al (2009) Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 68(8):1310–5

    Article  CAS  PubMed  Google Scholar 

  3. Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T (2010) IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 60(4):247–58

    Article  CAS  PubMed  Google Scholar 

  4. Brito-Zeron P, Ramos-Casals M, Bosch X, Stone JH (2014) The clinical spectrum of IgG4-related disease. Autoimmun Rev 13(12):1203–10

    Article  CAS  PubMed  Google Scholar 

  5. Pieringer H, Parzer I, Wohrer A, Reis P, Oppl B, Zwerina J (2014) IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis 9:110

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lu LX, Della-Torre E, Stone JH, Clark SW (2014) IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol 71(6):785–93

    Article  PubMed  Google Scholar 

  7. Dyck PJ, Boes CJ, Mulder D et al (2005) History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation. J Peripher Nerv Syst 10(2):158–73

    Article  PubMed  Google Scholar 

  8. Della TE, Bozzolo EP, Passerini G, Doglioni C, Sabbadini MG (2012) IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis. Ann Intern Med 156(5):401–3

    Google Scholar 

  9. Della-Torre E, Passerini G, Furlan R et al (2013) Cerebrospinal fluid analysis in immunoglobulin G4-related hypertrophic pachymeningitis. J Rheumatol 40(11):1927–9

    Article  PubMed  Google Scholar 

  10. Chan SK, Cheuk W, Chan KT, Chan JK (2009) IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol 33(8):1249–52

    Article  PubMed  Google Scholar 

  11. Choi SH, Lee SH, Khang SK, Jeon SR (2010) IgG4-related sclerosing pachymeningitis causing spinal cord compression. Neurology 75(15):1388–90

    Article  PubMed  Google Scholar 

  12. Lindstrom KM, Cousar JB, Lopes MB (2010) IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol 120(6):765–76

    Article  CAS  PubMed  Google Scholar 

  13. Tajima Y, Mito Y (2012) Cranial neuropathy because of IgG4-related pachymeningitis; intracranial and spinal mass lesions. BMJ Case Rep. doi:10.1136/bcr-2012-006471

    Google Scholar 

  14. Wallace ZS, Carruthers MN, Khosroshahi A et al (2013) IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 92(4):206–16

    Article  CAS  Google Scholar 

  15. Kosakai A, Ito D, Yamada S, Ideta S, Ota Y, Suzuki N (2010) A case of definite IgG4-related pachymeningitis. Neurology 75(15):1390–2

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lu Xin.

Ethics declarations

Disclosures

None.

Funding

China-Japan Friendship Hospital Youth Science and Technology Excellence project (2014-QNYC-B-11, 2014-QNYC-A-03).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lu, Z., Tongxi, L., Jie, L. et al. IgG4-related spinal pachymeningitis. Clin Rheumatol 35, 1549–1553 (2016). https://doi.org/10.1007/s10067-015-3104-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-3104-x

Keywords

Navigation